Joint last authors.
Original Paper
Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts†
Article first published online: 23 MAY 2012
DOI: 10.1002/path.4034
Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Additional Information
How to Cite
Simpkins, S. A., Hanby, A. M., Holliday, D. L. and Speirs, V. (2012), Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts. J. Pathol., 227: 490–498. doi: 10.1002/path.4034
- †
No conflicts of interest were declared.
- ‡
Joint last authors.
Publication History
- Issue published online: 10 JUL 2012
- Article first published online: 23 MAY 2012
- Accepted manuscript online: 4 APR 2012 07:03AM EST
- Manuscript Accepted: 29 MAR 2012
- Manuscript Revised: 9 FEB 2012
- Manuscript Received: 3 NOV 2011
- Abstract
- Article
- References
- Supporting Information
- Cited By
| Filename | Format | Size | Description |
|---|---|---|---|
| path_4034_sm_supportinginformationsfs1.tif | 1485K | Supporting Information: Figure S1. Immunofluorescent characterization of primary fibroblasts showed that over 95% of cells exhibited staining for vimentin (A) but were uniformly negative for cytokeratin 18 (B), cytokeratin14 (C), and the endothelial-associated CD31 (D). Approximately 30% of cells were positive for α-smooth muscle actin (E). Cav-1 immunostaining in normal fibroblasts is shown in F and is membranous. |
Please note: Wiley-Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

1096-9896/asset/PATH_left.gif?v=1&s=f8845e760fcc5be3e3baa6119dcc01c077e3db22)
1096-9896/asset/PATH_right.gif?v=1&s=86062495907b9532cd169b5a6605dac7fd14f581)
1096-9896/asset/cover.gif?v=1&s=9d27ae473c5444468836a93370dc054fd0ea594f)